Immunethep Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Immunethep General Information
Description
Developer of a biotechnology company intended to develop bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company offers therapies including the development of neonatal vaccines to protect neonates from bacterial infections inside the mother's womb. thereby enabling patients to develop their immunity and prevent multi-bacterial infections and diseases through advanced healthcare methods.
Contact Information
Website
www.immunethep.comCorporate Office
- Biocant Park Nucleo 04 Lote 3
- Cantanhede, 3060-197
- Portugal
Corporate Office
- Biocant Park Nucleo 04 Lote 3
- Cantanhede, 3060-197
- Portugal
Immunethep Timeline
Immunethep Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
8. Project Financing | 04-Jan-2023 | Completed | Pre-Clinical Trials | |||
7. Grant | 15-Jun-2022 | Completed | Pre-Clinical Trials | |||
6. Later Stage VC | Completed | Pre-Clinical Trials | ||||
5. Early Stage VC | 18-Oct-2018 | Completed | Pre-Clinical Trials | |||
4. Grant | 23-Oct-2017 | Completed | Pre-Clinical Trials | |||
3. Grant | 31-Mar-2017 | Completed | Startup | |||
2. Seed Round | 30-Mar-2015 | Completed | Startup | |||
1. University Spin-Out | 06-Oct-2013 | Completed | Startup |
Immunethep Comparisons
Industry
Financing
Details
Immunethep Competitors (1)
One of Immunethep’s competitors is MinervaX, a Venture Capital-Backed company based in Copenhagen, Denmark.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
MinervaX | Venture Capital-Backed | Copenhagen, Denmark |
Immunethep Patents
Immunethep Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3967326-A1 | Immunogenic compositions | Inactive | 10-Sep-2020 |
Immunethep Signals
Immunethep Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
European Innovation Council Fund | Venture Capital | Minority | ||
Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | |||
European Commission | Government | |||
Portugal Ventures | Venture Capital | Minority | ||
Venture Catalysts | Accelerator/Incubator | Minority |
Immunethep FAQs
-
When was Immunethep founded?
Immunethep was founded in 2013.
-
Where is Immunethep headquartered?
Immunethep is headquartered in Cantanhede, Portugal.
-
What is the size of Immunethep?
Immunethep has 13 total employees.
-
What industry is Immunethep in?
Immunethep’s primary industry is Drug Discovery.
-
Is Immunethep a private or public company?
Immunethep is a Private company.
-
What is Immunethep’s current revenue?
The current revenue for Immunethep is
. -
How much funding has Immunethep raised over time?
Immunethep has raised $580K.
-
Who are Immunethep’s investors?
European Innovation Council Fund, Bill & Melinda Gates Foundation, European Commission, Portugal Ventures, and Venture Catalysts are 5 of 6 investors who have invested in Immunethep.
-
Who are Immunethep’s competitors?
MinervaX is a competitor of Immunethep.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »